The global infantile spasm treatment market size was valued at US$ 111.1 million in 2017 and is expected to exhibit a CAGR of 3.1% over the forecast period (2018 – 2026).
Infantile spasm, also called as west syndrome, is a rare disorder that affects children below 1 year age. Seizures in children often appear as normal hiccups or body movement, and parents are unaware about the presence of this disease in their kid. Therefore, to tackle this challenge, various governments and organizations are initiating programs to educate people about the disease. The government of China published a comprehensive list of rare diseases in 2018, in order to better identify
... read more at: https://www.openpr.com/news/1706757/Infantile-Spasm-Treatment-Market-detailed-strategies-Competitive-landscaping-and-Top-Players-H-Lundbeck-A-S-Mallinckrodt-Pharmaceuticals-Catalyst-Pharmaceuticals-GW-Pharmaceuticals-Retrophin.html